10-Q: Aflac Reports Mixed Results in Q3 2024 Amidst Currency Volatility and Investment Losses
Quarterly Report
Aflac's Q3 2024 results were impacted by significant foreign exchange losses and investment losses, leading to a net loss for the quarter.
Summary
- Aflac reported a net loss of $93 million for the third quarter of 2024, a significant downturn compared to a net income of $1.6 billion in the same period last year.
- The company's total revenues decreased to $2.9 billion in Q3 2024 from $5.0 billion in Q3 2023.
- For the first nine months of 2024, Aflac's net earnings were $3.5 billion, down from $4.4 billion in the same period of 2023.
- The company experienced a pretax net investment loss of $1.4 billion in Q3 2024, a sharp contrast to a $423 million gain in Q3 2023.
- The average yen/dollar exchange rate was 147.95 in Q3 2024, a 2.0% weakening compared to 144.97 in Q3 2023, and 150.60 for the first nine months of 2024, an 8.1% weakening compared to 138.38 for the same period in 2023.
- Adjusted earnings for Q3 2024 were $1.2 billion, or $2.16 per diluted share, compared to $1.1 billion, or $1.84 per diluted share, in Q3 2023, with a negative impact of $0.03 per diluted share due to the weaker yen.
- Adjusted earnings for the first nine months of 2024 were $3.2 billion, or $5.64 per diluted share, compared to $3.0 billion, or $4.97 per diluted share, in the same period of 2023, with a negative impact of $0.17 per diluted share due to the weaker yen.
- Aflac repurchased 23.4 million shares for $2.1 billion in the first nine months of 2024 and has 54.3 million shares remaining for repurchase.
- Shareholders equity was $24.8 billion, or $44.60 per share, at September 30, 2024, compared to $22.0 billion, or $38.00 per share, at December 31, 2023.
Sentiment
Score: 4
Explanation: The document presents mixed results with a significant downturn in net earnings due to investment losses and currency volatility. While there are some positive aspects, the overall tone is cautious and reflects the challenges the company is facing.
Positives
- Aflac Japan's new annualized premium sales increased in yen terms due to the launch of a new life insurance product, Tsumitasu.
- Aflac U.S. new annualized premium sales increased due to growth in group life, absence management, disability products, and cancer insurance.
- Aflac U.S. experienced improved expense efficiency.
- Aflac Japan's pretax adjusted earnings increased due to a decrease in total benefits and claims and total adjusted expenses.
Negatives
- Aflac reported a net loss of $93 million for the third quarter of 2024, a significant downturn compared to a net income of $1.6 billion in the same period last year.
- The company's total revenues decreased to $2.9 billion in Q3 2024 from $5.0 billion in Q3 2023.
- The company experienced a pretax net investment loss of $1.4 billion in Q3 2024, a sharp contrast to a $423 million gain in Q3 2023.
- The average yen/dollar exchange rate was 147.95 in Q3 2024, a 2.0% weakening compared to 144.97 in Q3 2023, negatively impacting adjusted earnings.
- Aflac U.S. pretax adjusted earnings decreased due to an increase in total benefits and claims.
Risks
- The company is exposed to fluctuations in the yen/dollar exchange rate, which can significantly impact reported results.
- The company is exposed to credit risk, which can result in losses from defaults and credit downgrades of investments.
- The company is exposed to interest rate risk, which can impact the value of its investments and the cost of its debt.
- The company is exposed to equity risk, which can result in losses from fluctuations in market prices.
- The company is exposed to operational risks of third-party vendors.
- The company is exposed to tax rate changes.
- The company is exposed to competitive environment and ability to anticipate and respond to market trends.
- The company is exposed to catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics, tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, major public health issues, terrorism or other acts of violence, and damage incidental to such events.
Future Outlook
The company expects its effective tax rate on adjusted earnings for future periods to be approximately 20%. The company expects Aflac Japan to generate a benefit ratio in the range of 62% to 63% for the full year of 2024.
Management Comments
- Management evaluates the Company's financial performance both including and excluding the impact of foreign currency translation to monitor, respectively, cumulative currency impacts and the currency-neutral operating performance over time.
- Management uses adjusted earnings and adjusted earnings per diluted share to evaluate the financial performance of the Company's insurance operations on a consolidated basis and believes that a presentation of these financial measures is vitally important to an understanding of the underlying profitability drivers and trends of the Company's insurance business.
Industry Context
The document highlights the impact of currency fluctuations and market volatility on Aflac's financial results, which is a common challenge for multinational insurance companies. The company's focus on digital sales and new product development reflects broader industry trends towards innovation and customer experience enhancement.
Comparison to Industry Standards
- Aflac's performance is compared to its own historical results, but not directly to specific competitors. However, the document does mention that the company's share repurchase program is based on competitive practices.
- The document notes that the company's investment strategy incorporates asset-liability matching (ALM), which is a common practice in the insurance industry to align assets with liabilities.
- The document mentions that the company's discount rates are determined using upper-medium grade (low-credit-risk) fixed-income instrument yields, which is a standard practice in the insurance industry.
- The document mentions that the company's mortality rate assumptions are based on industry tables and adjusted for the Company's actual or expected experience, which is a standard practice in the insurance industry.
Stakeholder Impact
- Shareholders are impacted by the decrease in net earnings and the volatility in the share price.
- Policyholders are not directly impacted by the financial results, but the company's ability to meet its obligations is dependent on its financial health.
- Employees are impacted by the company's performance, which can affect compensation and job security.
- Creditors are impacted by the company's financial health, which can affect its ability to repay its debts.
Next Steps
- The company intends to execute a coinsurance transaction between Aflac Re and ALIJ in the fourth quarter of 2024.
- The company plans to continue to maintain a population of unhedged U.S. dollar-denominated investments at Aflac Japan and to consider whether the amount of such investments should be increased or decreased relative to the Company's view of economic equity surplus in Aflac Japan in light of potentially rising hedge costs and other factors.
Key Dates
| Date | Description |
|---|---|
| September 30, 2024 | End of the reporting period for the quarterly report. |
| October 24, 2024 | Date of the latest practicable date for share outstanding information. |
| November 1, 2024 | Date of the CEO and CFO certifications. |
| November 20, 2024 | Record date for the fourth quarter cash dividend. |
| December 2, 2024 | Payment date for the fourth quarter cash dividend. |
Keywords
Aflac, insurance, financial results, net earnings, adjusted earnings, investment losses, foreign exchange, yen, premiums, share repurchase, dividends, policy liabilities, credit risk, interest rate risk, equity risk
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.